The big medical sector is actually active in recent days, with strong crossing and repetition, which is closely related to the world epidemic situation. At the same time, there are constant relevant policy incentives to promote this big theme, and the big medical sector has been on a downward trend since the end of October last year. The overall pressure has actually been released, and it is now in the channel of repairing the upward trend, and this stage will naturally be concerned by funds. Then we should also pay close attention to this aspect in the footsteps of funds, but we should be aware that in this market, there are more local opportunities. Even in the same sector, the difference between the front row and the back row is very huge. Then only the front row with more traversal and repetition is worthy of our attention, because only in this way can we go further and get twice the result with half the effort. Therefore, we must play an extremely important role and pay attention to the opportunities in the front row.
1. Fosun Pharma
captures the hype: BNT162b1, a new crown mRNA vaccine authorized by its holding subsidiary, has been approved for clinical trials in China. It takes holding and investing in plastic surgery hospitals as the entry point to expand the layout of plastic surgery. A new crown nucleic acid detection kit developed by its subsidiary, fluorescence PCR, passed the emergency examination and approval in National Medical Products Administration. With the help of the existing second-generation assisted reproductive center in Shenzhen Hang Seng Hospital, it builds a three-level assisted reproductive specialist hospital platform in Shenzhen and even South China.
technical analysis: at present, it belongs to the shock platform after the acceleration of heavy volume. The actual turnover rate reaches 6.6%, and the current amplitude reaches 6.76%, which shows that neither of the long and short sides has gained absolute advantage at this stage, and it is more a game of balance. At this stage, we first observe 1 antennas, which is the core support of short-term emotions, and secondly observe that the quantity below can be extended. If the quantity below the sideways can't keep up for a long time, we must understand the stage control.
Inspector Magnifier: As a representative stock of biological vaccines, it is recognized for its funds in biological vaccines, and its recent market acceleration is partly due to the concept of medical beauty, and the latter part is due to vaccines, which shows that it now has not only the theme of biological vaccines, but also the theme of medical beauty and even the concept of reproduction. These concepts are basically hot concepts of big medical care, so as long as it takes the medical market, it will not be absent, but now the space above the position is available.
2. east China medicine
capture of hype: it is a leading domestic enterprise in research and development and production of drugs for diabetes and organ transplantation, and has its own place in the field of traditional Chinese medicine. At the same time, Sinclair company it acquired is a globally operated medical beauty company, and its holding subsidiary is a comprehensive medical beauty platform company that integrates research and development, production, sales and personalized customized services of medical beauty products.
technical analysis: at present, it extends the trend of 1 antennas, and the driving force is the theme of medical beauty. At present, it is in the shock stage, and its actual turnover rate is 7.48%, and its amplitude is 4.4%, which indicates that the long-short game is in the equilibrium stage. At this stage, 1 antennas are also very important for it, and the quantity and energy below it are not obviously released. Then this stage is a typical key node of the game, which is worth observing and paying attention to.
Inspector Magnifier: Inspector thinks that it can strengthen in the near future, mainly by taking the Medical Beauty Express, and it has the concept of traditional Chinese medicine. Now it strongly advocates the development of traditional Chinese medicine, and it naturally has room for expansion. In terms of medical beauty, its two big brothers, Langzi and Huanqiu, have all stepped out of a relatively beautiful trend. As a third brother, it has the opportunity to switch between high and low funds, but its stock nature likes to follow the trend rather than rocket launch. Therefore, the first focus is on the trend support line of 1 antennas, and the second focus is on the node opportunities after finishing. It is not necessary to chase high, and there will be more room for finding opportunities for stage finishing. Short-term customers sometimes suffer losses, and medium-and long-term investors often get the dividends of their growth.
3. Yunnan Baiyao
Opportunity capture: It is an old-fashioned proprietary Chinese medicine unique to Yunnan Province, China, and its brand is an old brand after a hundred years of development and a well-known trademark in China. It has an exclusive core pharmaceutical formula, and it has two subsidiaries to develop skin care business, and it also involves the field of facial mask.
technical analysis: it has sorted out the weak shocks in the early stage, and now it strikes back with 6 antennas and 3-week perimeter, which is a sign of financial concern from a technical point of view. According to its long-term form, it is currently at the bottom of a stage and has a large room for repair. At present, its actual turnover rate is only 2.18%, but its amplitude reaches 4.16%, which shows that the chips in it are better locked, with a small turnover.
Inspector Magnifier: Inspector thinks it is spatially available technically, so I won't talk about it here, but remember that it's not a rocket that is launched, but it will fluctuate during the period of strength under differences, but the general trend is upward. Logically, it belongs to a well-known brand, and many people have definitely heard of it before, so compared with other pharmaceutical companies, it has a broad mass base and its formula is also a national formula. Then it has a seat in the traditional field, and its recent development space is actually more expected to be that it attacks the field of skin care, and another field under the support of medical cents is cosmetics, so it begins to attack this piece, which naturally gives the capital imagination space, and it will naturally receive more attention. However, it should be clear that this piece has not been vigorously developed, so it will fluctuate in the short term, but it has broad growth in the medium and long term.
4. Ma Yinglong
Seize the hype opportunity: the first medicine in the field of hemorrhoid treatment. It will invest to set up Dajiang Co., Ltd., which is mainly engaged in research and development, production, wholesale and retail of cosmetics. It is an old-fashioned enterprise in China recognized by the Ministry of Internal Trade.
technical analysis: it recently went out of the counterattack in heavy volume, breaking the previous weak shock, but after the counterattack, it was repeated back and forth along the 1 antennas, which was obviously in a divergent stage. From its actual turnover rate, it was 4.62%, but the amplitude was only 2.91%. It was contrary to Baiyao, which was characterized by more hot money and strong disagreement. So technically, it was a short-term repetitive opportunity, and the core support point was 11.
Inspector Magnifier: Many friends may say Inspector. It's similar to Baiyao, but it's not the case from the perspective of speculation opportunities. The fund recognizes Baiyao's medium and long hair exhibition, while the fund for Ma Ying is more for short-term speculation. Its opportunity point is also the superposition of traditional Chinese medicine and skin care cosmetics, so it's better not to chase after it, and it's better to find different nodes. What it expects is actually that after the concept of medical beauty has been speculated, When the capital flows into the cosmetic direction related to medical beauty, it will have the opportunity to take a wave of extension. Before that, it is more of a trend opportunity to stand at 1 antennas, so the first thing to observe it is to pay attention to 1 antennas, and the second is the continuity of quantity and energy.
The above are the four medicine concept leaders. Please leave a message below to discuss what you have to add.
Welcome everyone to like, pay attention to, collect and forward. Your support is my motivation to update dry goods.
I'm Inspector Chen in the stock market, a professional financial analyst covering many fields of finance. I have rich working experience for many years, and I look at problems from multiple perspectives. I'm good at grasping market sentiment, judging leading opportunities, paying attention to Inspector Chen in the stock market, and I'm no longer confused and regretful because I missed it.